Cytosorbents Corp
CTSO
53 hedge funds and large institutions have $24.7M invested in Cytosorbents Corp in 2024 Q3 according to their latest regulatory filings, with 8 funds opening new positions, 9 increasing their positions, 14 reducing their positions, and 5 closing their positions.
110% more capital invested
Capital invested by funds: $11.8M → $24.7M (+$13M)
60% more first-time investments, than exits
New positions opened: 8 | Existing positions closed: 5
6% more funds holding
Funds holding: 50 → 53 (+3)
0.37% less ownership
Funds ownership: 30.67% → 30.3% (-0.37%)
36% less repeat investments, than reductions
Existing positions increased: 9 | Existing positions reduced: 14
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Neuberger Berman Group
New York
|
+$268K |
| 2 |
SIG
Sargent Investment Group
Bethesda,
Maryland
|
+$211K |
| 3 |
AE
AMH Equity
Great Neck,
New York
|
+$90.8K |
| 4 |
AFG
Atomi Financial Group
New York
|
+$37.6K |
| 5 |
Geode Capital Management
Boston,
Massachusetts
|
+$35.5K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
GIM
Granahan Investment Management
Waltham,
Massachusetts
|
-$624K |
| 2 |
SC
Skylands Capital
Milwaukee,
Wisconsin
|
-$93.6K |
| 3 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$86.4K |
| 4 |
CM
CM Management
Gulf Breeze,
Florida
|
-$54.8K |
| 5 |
BlackRock
New York
|
-$31.3K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
AF
51
Allworth Financial
Folsom,
California
| $56 | – | – | – |
|
52
PNC Financial Services Group
Pittsburgh,
Pennsylvania
| $47 | – | – | – |
|
53
BNP Paribas Financial Markets
Paris,
France
| $4 | – | – | – |
|
54
Millennium Management
New York
| – | -$14K | -19,941 | Closed |
|
55
Jane Street
New York
| – | -$9.45K | -13,446 | Closed |
|
|
RWMG
56
Redwood Wealth Management Group
Medford,
New Jersey
| – | -$5.76K | -8,200 | Closed |
|
57
Qube Research & Technologies (QRT)
London,
United Kingdom
| – | -$1 | -1 | Closed |
|
CTSO Hedge Fund Activity: Q3 2024 in Review
53 of the 6,964 institutional investors tracked by Wall St. Rank reported a position in Cytosorbents Corp (CTSO) for Q3 2024, worth a combined $24.7M — up 110% from $11.8M a quarter earlier.
Buyers outnumbered sellers: 8 funds opened new CTSO positions and 5 closed out — a net gain of 3 holders — while 9 added to existing stakes and 14 trimmed.
The largest buyer was Neuberger Berman Group, adding an estimated $268K. The largest seller was Granahan Investment Management, cutting an estimated $624K.
- 53 institutional investors held Cytosorbents Corp (CTSO) as of Q3 2024, up from 50 in Q2 2024.
- Funds reported $24.7M of Cytosorbents Corp stock for Q3 2024, up 110% quarter-over-quarter.
- 8 funds opened new Cytosorbents Corp positions in Q3 2024 and 5 closed out, a net change of +3 holders.
- The largest Cytosorbents Corp buyer in Q3 2024 was Neuberger Berman Group, an estimated $268K added.
- The largest Cytosorbents Corp seller in Q3 2024 was Granahan Investment Management, an estimated $624K sold.
Based on aggregated 13F filings for Q3 2024.